Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Emulate raises $28mm in Series B round; later expands round with an additional $17mm
21 Oct 2016
Organs-on-Chips company Emulate Inc. raised $28mm in its Series B financing round. Existing investors Hansjörg Wyss, NanoDimension, and Cedars-Sinai Medical Center were joined by new investors OS Fund, Atel Ventures, the Leandro P. Rizzuto Foundation (ALS Finding a Cure), and Laboratory Corp of America Holdings. Proceeds will be used to advance the company's product design and development including for the launch of the Human Emulation System; for expansion of the Organ-Chip portfolio beyond liver, lung, intestine and skin; and for acceleration of disease-state applications for Organ-Chips.
Drug Discovery Tools
Nanotechnology, Chips, etc.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?